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Abstract
Zingiber officinale, belonging to the family Zingiberaceae, is a popular spice and 
herb used as delicacy and to manage numerous diseases such as diabetes, hyperten-
sion, cancer, ulcer, diarrhea, cold, cough, spasm, vomiting, etc. in folk medicine 
from China, India, and Arabia Peninsula to other continents of the world including 
Africa (Nigeria, Egypt, and so on). Though this review is aimed at summarizing 
the pharmacological potentials of this well-endowed spice, interestingly, we found 
out that these reported ethnobotanical uses are attributed to a number of inherent 
chemical constituents including gingerol, 6-, 8-, 10-gingerol, 6-shogaol, 6-hydro-
shogaol, oleoresin, etc., eliciting various pharmacological effects, not limited 
to antioxidant, antitumor/anticancer, anti-inflammatory, antihyperglycemic, 
antihypertensive, anticholesterolemic, antibiotic/antimicrobial, neuroprotective, 
antiulcer/gastroprotective, antiemetic, hepatoprotective, and antiplatelet aggrega-
tion, safety profiles established through a number of studies (in vitro, in vivo, and 
cell lines), though some of these potentials are yet to be explored. Sadly, even few of 
these established effects are yet to be experimented in clinical trials, and only until 
these are intensified would there be prospect toward drug development for preven-
tive and curative treatments. In conclusion, we are able to highlight and sum up the 
therapeutic implications of ginger and its related derivatives in the management of 
ailments confronting humanity.
Keywords: ginger, spice, pharmacological potentials, gingerol, 6-, 8-, 10-gingerol, 
6-shogaol, 6-hydroshogaol, oleoresin
1. Introduction
Ginger (Zingiber officinale Roscoe) is a well-known herbal spice believed to 
have originated from either India [1] or Southeast Asia [2]. It is a sterile plant, thus 
reproduced by rhizomes, not by seeds [3], and grows well in tropical and subtropi-
cal regions of the world [4]. It is used for culinary purposes, as a seasoning or 
condiment and as a therapeutic agent [5]. It is known to be an effective spasmolytic, 
antipyretic, antiemetic, antioxidant, antiulcer, analgesic, hypotensive, antidiabetic, 
and anti-inflammatory agent [6, 7] containing scented essential oils and spicy oleo-
resins [8]. Ginger has long been in use therapeutically and currently still validated 
as a potent medicinal spice for the treatment of various ailments. Indigenously, it 
has been used against colds [9], sore throats [10], and Staphylococcus aureus [11] 
and tested effectively against cancer cells [12]. Ginger can be used as a dietary 
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supplement and as additives in the production of various snacks and merchantable 
products [13]. Additionally, it is considered a safe herbal drug [14], as the spices 
have been categorized to be generally regarded as safe: “GRAS.”
2. Botanical description, occurrence, and distribution
Zingiber officinale (Roscoe), ginger of the family Zingiberaceae, is an herbaceous 
(available as rhizomes) perennial plant growing as tall as 90 cm. The leaves, lanceo-
late, appear to be simple, alternate, distichous, narrow, long possessing sheathing 
bases with 2–3 cm broad, while the rhizomes (7–15 cm long and 1–1.5 cm broad) are 
aromatic, thick lobed with pale yellow coloration. The flowers are small, have calyx 
that are lofty, have sepals very united, are three toothed, and split open on a side with 
three subequal corolla forming an oblong to lanceolate connate segment with green 
coloration [15, 16]. Ginger give rise to numerous lateral clump shoot which on matu-
ration appeared dry. Ginger originate from Southeast Asia predominately in India but 
now well distributed or cultivated in China, Bangladesh, Australia, and Nigeria [17].
3. Ethnobotanical uses
Ginger had been used medicinally since time immemorial with documented use 
from Sanskrit, Chinese, Greek, Arabic, and Roman ethnomedicine book. However, 
in the ninth century, Europe recognized the indigenous use of this wonderful spice, 
and England followed suit in the tenth century. Ginger is used in folkloric medicine 
for indigestion, high blood pressure, arthritis, intestinal and throat infections, 
vomiting, nausea, lung diseases, cold, cough, pain, swellings, etc. [15, 17, 18]. Other 
nutritional uses are found in condiment, beer, wine, and so on [18].
4. Phytochemistry of ginger
Ginger, a spice of diverse health benefits, has been found to be rich in nonnutri-
tive and biologically active compounds known as phytochemicals [19, 20], which 
have been linked to its health functions. The nutritional and therapeutic values 
have been recognized in its nutraceutical benefits linked to the presence of certain 
phytochemicals contained in it. The use of ginger as a nutraceutical agent is not only 
attributed to its health-augmenting benefits but also to its availability, affordability, 
and safety.
More than 400 compounds have been found in the chemical analyses of ginger 
[21]. These compounds includes alkaloids; saponins; flavonoids; steroids; tannins; 
carbohydrates; glycosides; proteins; amino acids; dietary fiber; ash; phytosterols; 
vitamins A, B, and C; minerals; and terpenoids [22–24] while detected to be devoid 
of acid compounds and reducing sugars [23].
The main components of the ginger rhizome are in the order carbohydrates, 
lipids, terpenes, and phenolic compounds [25]. The terpenes and the phenolic 
compounds make up the two foremost classes of phytochemicals in ginger [26]. 
Phenolic compounds of ginger are also referred to as its nonvolatile components, 
which have been incriminated in its pharmacological activity. They consist of gin-
gerols and its 6, 8, and 10 derivatives and the corresponding series of homologous 
shogaol and zingerone, obtained from heat or alkali treated gingerols [26]. Shogaol, 
paradol, and gingerols have been depicted to be responsible for the pungent taste 
and smell of ginger [1, 27]. The terpene components of ginger, sesquiterpenes and 
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monoterpenes, are believed to be the volatile fractions [27]. The sesquiterpenes are 
thought to be a major contributor to the savor of ginger, while the monoterpenes are 
referred to as the most abundant terpenes in fresh ginger oil [24]. The main sesqui-
terpenes, zingiberene and β-bisabolene, are responsible for its aromatic scent, while 
others include α-farnesene, β-sesquiphellandrene, and α-curcumene [21].
Phenolic compounds of ginger are majorly derived from fresh ginger rhizomes, 
while the terpenes are derived from distillation of ginger oils [26] although their 
quantity has been found to vary depending on the region of germination. This 
may be dependent on climate or edaphic conditions as well as genetic variations 
[28]. The pungent compounds (gingerols, methyl gingerols, shogaols, paradol, and 
gingerdiones), volatile oil, and other compounds extracted by means of ethanol or 
acetone constitute the oleoresin [29, 30]. Volatile oils are about 1–4%, lipids about 
6–8%, proteins about 9%, and carbohydrates about 50–80% [28] while geraniol is 
the major essential oil derived in ginger [8].
Zingerone, geraniol, gingerols, shogaols, gingerdiols, gingerdiones, and dehydro-
gingerdiones have been reported to have antioxidant activity; 6-, 8-, and 10-gingerol 
and 6-gingerdiol possessed antifungal activity. While 6-gingerol had established 
antidiabetic and reno-protective activities, zingerone, 6-shogaol, 6-gingerol (anti-
cancer, anti-obesity, and gastroprotective activities), and gingerol and its pungent 
derivatives (anti-inflammatory activity), 6-shogaol (analgesic, neuroprotective, and 
strong gastroprotective activities), 6-gingerol, and 6-shogaol, acted against platelet 
aggregation; 10-gingerol had larvicidal activity; and 6-, 8-, 10-gingerol possessed 
inotropic activity [24].
5. Pharmacological potentials
The review from most countries of the world such as Egypt [20], Korea [17], 
Pakistan [15], India [16, 31, 32], Oman [5], Brazil [33], Canada [34] etc. had 
established the pharmacological potentials of this popular plant, Zingiber officinale 
(Roscoe), used most times as spice. Additionally, while some reports centers on 
the action of ginger, others point to the effect of its active components as they 
target specific diseases including but not limited to diabetes [35], inflammation 
[25], cancer [22], emetics [36], nausea and vomiting [37] and so on. Thus, the 
pharmacological potentials (antioxidant, anticancer, antitumor, anti-inflammatory, 
antihyperglycemic, antihypertensive, anticholesterolemic, antimicrobial, neuro-
protective, antiulcer, antiemetic, hepatoprotective) and toxicity profiles of ginger 
as submitted in these reports are presented one after the other below.
5.1 Antioxidant
The overproduction of free radicals (ROS) in situation where the antioxidant 
defense mechanism is compromised results into a state of oxidative stress. In order 
to overcome the excessive free radical (FR) generation and oxidative stress, anti-
oxidants play an important role. Numerous medicinal plants (MPs) and/or their 
constituents have established their prominence in preventing the onset of diseases 
particularly those triggered by FR. Ginger, a good example of MPs with excellent 
antioxidative effect, has been found to exert this action by lowering peroxidation 
of lipid such as the inhibition of ascorbate/ferrous complex in rat liver microsomes 
as cited by Rahmani et al. [20] and Mele [17] in the report of Reddy and Lokesh 
[38] using a concentration of 150 mM (Table 1). Ginger or its derivatives (extracts, 
compounds, or active components) and gingerol are found to have good scaveng-
ing effect against superoxide anion and hydroxyl radicals [63–65]. In fact, further 
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Ginger/derivatives Potentials Assay(s) employed Type of 
study
Concentration(s) tested Extracts  
(if any)
Country 
(where the 
report is 
published)
References 
Ginger Antioxidant Lipid peroxidation In vivo 
(rats)
150 mM NI India Reddy and 
Lokesh, [38]
Ginger extracts Hepatoprotective Thioacetamide-induced 
(200 mg/kg i.p)
In vivo 
(rats)
250, 500 mg/kg Ethanol Malaysia Bardi et al., [39]
Ginger extracts Antiproliferative Hep G2 cells Cell lines NI Ethanol Malaysia Bardi et al., [39]
6-gingerol Antioxidant, 
anti-inflammatory
UVB-induced intracellular 
reactive oxygen species 
levels
In vitro 
and 
in vivo 
(mice)
NI (200 μL) Acetone South Korea Kim et al., [40]
Ginger Antioxidant, antidiabetic MDA, FRAP 
streptozotocin-induced
In vitro 
and 
in vivo 
(rats)
5% ginger in daily foods NI Iran Afshari et al., [41]
Oleoresin, 6-gingerol, 
8-gingerol, 
10-gingerol, 6-shogaol, 
6-hydroshogaol
Antioxidant, 
antimicrobial, 
anti-inflammatory
Nitric oxide, ABTS, DPPH, 
Disc diffusion
In vitro NI NI India, Algeria Dugasani et al., 
[42]; Li et al., [43]; 
Bellik, [44]
Ginger Anticancer (prostrate 
and liver)
0.1% ethionine-induced In vitro 
and 
in vivo
100 mg/kg NI USA, Malaysia Karna et al., [45]; 
Habib et al., [46]
Ginger extracts Anticancer (pancreas) Panc-1 cells Cell 
lines, 
in vivo
NI Ethanol Japan Akimoto et al., 
[47]
Anti-inflammatory, 
analgesic, hypoglycemic, 
safety profile
Hind paw In vitro 
and 
in vivo
50–800 mg/kg Ethanol South Africa Ojewole, [48]
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Ginger/derivatives Potentials Assay(s) employed Type of 
study
Concentration(s) tested Extracts  
(if any)
Country 
(where the 
report is 
published)
References 
Ginger oil Antiarthritis, 
anti-inflammatory
Hind paw In vivo 33 mk/kg NI Malaysia Sharma et al., [49]
Ginger Antidiabetic Streptozotocin -induced In vivo 100, 300, 500 mg/kg bw Aqueous Malaysia Abdul Razaq et al., 
[50]
Ginger Antidiabetic Standard 
spectrophotometric 
methods (glycation 
inhibition, glucose 
diffusion)
In vitro 5, 10, 20, 40 g/L Aqueous Pakistan Sattar et al., [51]
6-gingerol Antidiabetic Streptozotocin-induced In vivo 25, 50 mg/kg bw Aqueous Malaysia Sukalingam et al., 
[52]
Ginger, 6-, 8-, and 
10-gingerol, while 
6-shogaol
Antihypertensive Pentothal -induced In vivo 3–10 mg/kg Aqueous Pakistan Ghayur et al., [53]
Ginger Anticholesterolemic NI In vivo 50, 500 mg/kg Aqueous Kuwait Thompson et al., 
[54]
Ginger Antibacterial Disc diffusion In vitro 0.125, 0.25, 0.5, 1.0%
35.25, 75, 250, 500 mg/ml
20, 40, 60, 80, 100 g/ml
Ethanol, 
ethyl 
acetate, 
n-hexane
aqueous, 
ethanol
aqueous, 
ethanol
Nigeria
Nigeria
Malu et al., [55]
Ekwenye and 
Elegalam, [56]
Sebiomo et al., 
[57]
Oleoresin, essential oil Antifungi and 
antibacterial 
(antimicrobial)
Disc diffusion In vitro NI (3 uL) NI Algeria Bellik, [44]
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Ginger/derivatives Potentials Assay(s) employed Type of 
study
Concentration(s) tested Extracts  
(if any)
Country 
(where the 
report is 
published)
References 
Ginger Neuroprotective Monosodium 
glutamate-induced
In vivo 100 mg/kg Aqueous Saudi Arabia Waggas, [58]
Ginger
6-gingerol
Gastroprotective HCl-ethanol induced In vivo 1000 mg/kg
100 mg/kg
Acetone Japan Johji et al., [59]
6-gingerol, 6-shogaol Gastric suppression Hexobarbital induced In situ 1.75–3.5 mg/kg (i.v), 
70–140 mg/kg (oral)
NI Japan Suwekawa et al., 
[60, 61]
Ginger Hepatoprotective Carbon 
tetrachloride-induced
Acetaminophen-induced
In vivo
In vivo
100 mg/kg (singly), 
50 mg/kg (combination 
with 100 mg/kg 
curcumin)
200, 400 mg/kg
NI
Aqueous 
ethanol
Egypt
India
Abdullah et al., 
2016
Ajith et al., [62]
NI: Not indicated
Table 1. 
Pharmacological potentials of ginger and its derivatives.
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reports indicated that upon further heating (ginger), this activity remained 
unaffected [66]. Furthermore, it diminishes the ultraviolet B (UVB)-induced 
intracellular reactive oxygen species (ROS) and cyclooxygenase (COX)-2 in in vitro 
and in vivo studies [40]. Other derivatives of ginger such as oleoresin, 6-shogaol, 
6-dehydroshogaol, 1-dehydro-6-gingerdione, 6-gingerol, 8-gingerol, 10-gingerol, 
and essential oil possess pharmacological activities such as antioxidant, antimicro-
bial, etc., against 2,2-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS), 
1,1-diphenyl-2-picrylhydrazyl (DPPH), hydroxyl radical, and microbial strains such 
as Bacillus subtilis, Bacillus cereus, Staphylococcus aureus, Escherichia coli, Candida 
albicans, Penicillium spp., and Aspergillus niger [42–44].
5.2 Antitumor/anticancer
Cancer is one of the noncommunicable diseases with great negative impact on 
global population. It is caused by persistent increase in abnormal human body cells 
leading to the formation of tumors (of malignant cells) with the possibility to be 
metastatic [67]. The continuous multiplication of these cells is sometimes associ-
ated to influence oxidative stress. A number of treatment (chemotherapy, radio-
therapy, synthetic drugs, etc.) are currently available; however, they come with 
one or several side effects (nausea, hair fall), hence, the need for alternative form 
of treatment or therapy particularly from MPs. In recent times, quite a number of 
plant species had found their relevance in the prevention and treatment of cancer, 
and efforts of researchers to continually develop new moieties are overwhelming. 
Ginger is a great example of such MPs with excellent prophylactic and curative 
anticancer properties. Although it must be noted that these effects are not available 
for all cancer types, several reports on ginger and its derivative (gingerol) have 
established numerous effects on different types of cancer (lung, colon, ovar-
ian, prostrate, etc.) in a study conducted in the United States by Karna et al. [45] 
however, daily oral administration of ginger at a concentration of 100 mg/kg body 
weight (bw) inhibited PC-3 xenograft growth, indicating its effect against prostate 
cancer in vitro and in vivo. Additionally, the same concentration in another study 
[46] reduced the increased activity of tumor necrosis factor-alpha (TNF-α) due 
to the blockage of rat’s liver cancer. Its effect on Panc-1 cells and other cell lines in 
an in vitro and animal model had been established against cancer of the pancreas, 
while combining the spice with other spices such as garlic and turmeric provided 
effectiveness against breast cancer [68]. In line with the aforementioned effects, 
derivatives of ginger, e.g., 6-shogaol, 8-shogaol, 10-shogaols, 6-gingerol, 6-paradol, 
and zingerone in several studies had also exhibited activities against different 
form of cancer including lung, colon, colorectal, ovarian, prostrate as cited by 
Rahmani et al. [20] and Gunathilake and Rupasinghe [34] from numerous studies. 
Interestingly, ginger was also reported to hinder tumor growth achieved through 
different molecular mechanism such as upregulation of suppressor gene, apoptosis, 
induction, and inactivation of vascular endothelial growth factor (VEGF) (molecu-
lar pathways), a tumor angiogenic factor that triggers tumor development and 
progression [20].
5.3 Anti-inflammatory
Inflammation is a response (defense) felt by the body to dangerous stimuli such 
as injury to tissues or allergens. However, when these responses are beyond normal, 
it manifest into arrays of derangements including but not limited to allergies, cancer, 
autoimmune disorder, metabolic syndrome, and cardiovascular diseases [69]. 
Interestingly, there are reports of relationship between oxidative stress-triggered FR 
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and inflammation. The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is 
employed to ameliorate acute and chronic types of inflammation. NSAIDs exhibit 
this action by inhibiting the enzyme (cyclooxygenase, COX 1 and 2, and/or lipoxy-
genase, 5, 10, 15) involved in the breakdown of arachidonic acid to prostaglandins. 
Unfortunately, there are numerous side effects emanating from the use of NSAIDs, 
hence the search for alternative form of treatment with minimal or no side effects 
in natural products. Intriguingly, numerous MPs have shown to be effective against 
inflammatory diseases. Ginger, an example of such MPs including its derivatives, has 
been reported to possess anti-inflammatory potentials [17] in vitro and in vivo stud-
ies [34]. Ojewole [48] submitted the analgesic, anti-inflammatory, hypoglycemic, 
and safety effect of ginger extract at a dose range of 50–800 mg/kg bw (Table 1). 
Thirty-three mg/kg bw ginger oil given to rats also alleviated acute and chronic 
arthritis [49]. Interestingly, ginger exhibits its anti-inflammatory activity in other 
solvents aside water (used in folkloric medicine), as the reports of Rani et al. [70] 
corroborate this when ethyl acetate-extracted ginger revealed the best anti-inflam-
matory effect better than water, methanol (polar solvents), and hexane (nonpolar) 
against cyclooxygenase and lipoxygenase known as anti-inflammatory enzymes 
as cited by Gunathilake and Rupasinghe [34] and Mele [17] from various reports. 
Additionally, ginger plays a very good role in regulating the release of mediators 
(nitric oxide, prostaglandins), cytokines, TNF, and interleukin (IL)-1, IL-8, via 
several biochemical pathways attributed to inflammation, etc. [17, 20, 25, 33, 34].
5.4 Antihyperglycemic
Diabetes mellitus (DM) is one of the noncommunicable diseases with major 
prevalence globally. It is an endocrine disorder or metabolic derangement character-
ized by hyperglycemia (elevated level of glucose in the blood) due to insufficient or 
ineffective insulin arising from abnormalities in carbohydrate, lipid, and protein. 
The treatment or management of DM could be non-pharmacological (exercise, 
dietary regimen) or pharmacological which entails the use of oral hypoglycemic 
agents (OHAs) such as sulphonyl ureas, biguanides, and so on. However, the use of 
these chemicals or synthetic agents is prone to side effects (obesity), unavailability, 
and unaffordability, hence the dire need for alternative form of treatment with little 
or no side effects. Surprisingly, these qualities are now found in medicinal plants. 
In fact, the World Health Organization in a number of their technical reports 
advocated and encouraged the use of MPs for diabetic control and management. 
It is interesting to note that quite avalanches of MPs have found their relevance as 
antidote to curing diabetes [71] and some of its related complications. Ginger is 
one of such MPs traditionally used to salvage diabetes. In fact, numerous reports 
are available in the literature [17, 34, 35] establishing the potential of this spice 
in in vitro and in vivo studies. A similar example is the report of Ojewole [48] as 
submitted previously in a section (above) of this report. Similarly, 500 mg/kg bw 
of its aqueous extract lowers plasma sugar level following streptozotocin induction 
[50] in animal model and in vitro [51]. Since there is a report of correlation between 
oxidative stress and DM [20] as well as other complications of DM such as hyperlip-
idemia, hypercholesterolemia, retinopathy, and neuropathy, various publications 
had revealed the potentials of ginger and its derivatives against these complications 
as cited by Gunathilake and Rupasinghe [34].
5.5 Antihypertensive
Hypertension, a silent killer (because it shows no symptoms), is characterized 
by continuous increase in blood pressure in the arteries of a person. It occurs 
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when the systolic and diastolic blood pressures rise above 140/90 mmHg, respec-
tively. Findings revealed excessive salt intake, smoking, alcohol consumption, 
narrowing of the kidney, and use of birth control pills as some of the causes of 
hypertension, a risk factor to many cardiovascular diseases (CVD). Like diabetes, 
the treatment option may be non-pharmacological (lifestyle modification, etc.) 
or pharmacological involving the use of synthetic moieties such as diuretics, 
beta blockers (atenolol), angiotensin-converting enzyme inhibitor (Lisinopril), 
calcium channel blockers, etc. [72]. However, sadly too, all these antihyperten-
sive agents bring about grievous adverse effects such as angioedema, dry cough, 
weakness, headaches, etc.; thus, there is need for a substitute form of therapy for 
sufferers of high blood pressure (HBP). Herbal products from MPs have come 
very handy in the fight geared toward treating HBP, and a notable example of 
such plant is ginger. In a study involving rats and guinea pigs, extracts of ginger 
at concentration range of 0.3–3 mg/kg lower the arterial blood pressure of these 
animals [34]. Additionally, similar study using ginger aqueous extract and its 
derivatives revealed similar action [53] (Table 1). The activity of ginger as anti-
hypertensive agent was also corroborated in a study [73] involving human subject 
when twice daily intake of 10 g of the spice reduced the arterial blood pressure to 
94.80 mmHg after 2 months. It is worthy of mention that the mechanism of the 
established action of this spice was through the stimulation of muscarinic recep-
tors and calcium channel blockage.
5.6 Anticholesterolemic
Cholesterol is a constituent of the plasma membranes (eukaryotic) repre-
senting sterols [74], needed for growth and development of higher organism. 
Hypercholesterolemia occurs when there is an elevated level of cholesterol 
though it suffices to say that there are good (high-density lipoprotein cholesterol 
(HDL-c)) and bad (low-density lipoprotein cholesterol (LDL-c)) cholesterol. 
Hypercholesterolemia is a risk factor to many diseases including CVD, atheroscle-
rosis, myocardial infarction (MI), etc. [75] and there are reports of high level of 
cholesterol in the blood on the influence of excessive production of FRs [76–78]. 
The use of herbal medicines or MPs for therapeutic/curative or preventive measures 
against diseases is an age-long tradition [79]. Ginger is one of such herbal medicine 
with cholesterol-lowering properties. In a study by Thomson et al. [80] as cited by 
Gunathilake and Rupasinghe [34], oral administration of 500 mg/kg bw of aqueous 
extract brought down elevated level of cholesterol in Wistar rats. Another study 
using mice revealed a 29% reduction in the cholesterol level and other lipid profiles 
on the administration of 250 μmkg ethanolic extract studied on rabbits [81] and rats 
(100, 400 mg/kg bw) in a high-fat diet-fed rodents [82]. In the same vein, a study 
on human subject revealed a positive coadministration of atorvastatin (low dose) 
and ginger reducing cholesterol level in the blood particularly those subjects suffer-
ing from hepatic lesion or inflammation [83].
5.7 Antibiotic/antimicrobial
Infectious diseases are becoming the fastest cause of death globally. A number of 
bacterial etiological agents cause infections, and the use of antibiotics has become a 
panacea treatment to the ravishing effects of these microbiological agents. However, 
it is worthy of mention that the use of antibiotics despite their side effects is in 
recent times becoming ineffective due to the resistance of these microorganisms 
which is rapidly increasing [20]. In fact, as a result of these unpalatable trend in the 
antibiotics use, ongoing efforts have embraced the use of MPs in treating infectious 
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ailments, and a number of plants such as ginger are endowed with established 
antimicrobial effects as reflected in arrays of in vitro, in vivo, and preclinical 
studies using different solvents of extraction (ethanol, ethyl acetate, hexane) to 
inhibit microbial growth as presented by Rahmani et al. [20] and Gunathilake and 
Rupasinghe [34] from many submissions. Ginger derivatives such as 6-dehydro-
gingerdione, 6-gingerol, 10-gingerol, and 6-shogaol have established antibacte-
rial effects against strains of bacteria and mycobacterial including Acinetobacter 
baumannii, Helicobacter pylori, Mycobacterium avium, and M. tuberculosis [17, 20, 
34]. Interestingly, to corroborate the effectiveness of ginger and/or its derivatives, 
a report of potency surpassing common synthetic antibiotics in the fight against 
infectious diseases is noted [17, 34, 57].
5.8 Neuroprotective
Neuroprotection refers to the way and manner the central nervous system 
(CNS) is shielded from neuronal damages resulting from acute and/or chronic 
neurodegenerative disorders (such as stroke, Alzheimer’s, Huntington’s, Parkinson’s 
diseases) as a consequence of CNS neurons breakdown and/or worsening of the 
cognitive or intellectual reasoning of the patients [84]. Intriguingly, the emergence 
of neurodegenerative diseases (NDD) is age-related, i.e., as individual age, so the 
possibility of suffering from NDD [85]. Medicinal plants such as ginger have con-
tinued to find its place in the management and/or treatment of diseases particularly 
NDD, and these effects are attributed to its inherent phenolic and flavonoid com-
pounds [17, 20]. A root extract of ginger at 100 mg/kg bw extenuates the effect of 
monosodium glutamate-induced toxicity in rats (Table 1). The emergence or onset 
of many diseases is triggered by the production of FRs; similarly, since one of the 
complications of DM is neuropathy, hence, a relationship between FR, NDD, and 
diabetes is noted. Actually, ginger in separate studies was reported to promote or 
strengthen the antioxidant defense mechanism of the rat’s brain following strepto-
zotocin induction [86–88]. Furthermore, 6-shogaol was studied to inhibit microglia 
in transient global ischemia [89].
5.9 Antiulcer/gastroprotective
Ulcer (gastric or duodenal) is also a disease affecting majority of the populations 
of the world for more than ten (10) decades now [90], caused by discrepancies 
between the protective factors (bicarbonates, prostaglandins, mucin, nitric oxide) 
and aggressive factors (acid and pepsin) leading to a great deal of mortality and 
morbidity. Several factors [etiologic (Helicobacter pylori) or otherwise, e.g., sed-
entary lifestyle, diet, drug (NSAIDs), smoking, bacterial infection, free radicals, 
etc.] influence the emergence and/or progression of ulcer. The treatment involves 
the use of antimicrobial drugs (metronidazole, tetracycline, amoxicillin, etc.) 
geared toward eliminating H. pylori, antisecretory agents (omeprazole and so on), 
antagonist of H2 receptors (cimetidine, ranitidine, etc.), and other agents targeting 
the disruption of the cell wall or membrane of the bacteria (bismuth salt). However, 
these series of therapies bring about toxicities, thus the clamor for the alternative 
form of treatment with little or no toxicities, qualities found in medicinal plants 
such as ginger. The antiulcerative action of ginger is achieved via the elevation of 
mucin production [20] and enzyme (thromboxane synthetase) inhibition [17]. A 
number of studies proving the gastroprotective properties of ginger and some of its 
constituents such as 6-gingerol and 6-shogaol had been established as compiled or 
presented in the work of Rahmani et al. [20].
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5.10 Antiemetic
Ginger in a study using rodents was found to possess anti-serotonin and 5-HT3 
receptor antagonism effect in inducing nausea and vomiting during post-surgery 
[91]. Derivatives of ginger such as gingerol, shogaols, galanolactone, and diterpe-
noid were also established to reduce nausea and vomiting [92]. Others revealed 
that the reports of management of nausea and vomiting in cancer patients are also 
available in the literature [93].
5.11 Hepatoprotective
The liver is the second largest organ (after the skin) in the body where metabo-
lism of drugs or chemical substance occurs. Hence, important attention is required 
for this organ for good health status and well-being. Liver ailments also constitute a 
major health problem in the world today caused sometimes by exposure or inges-
tion of toxic chemicals (carbon tetrachloride, thioacetamide, certain antibiotics, 
excessive alcohol intake, etc.), and the use of conventional drugs for the treatment 
of liver diseases is ineffective and comes with side effects. However, solace has 
been found with MPs such as ginger as alternative means to treating these ailments. 
Report of relief from liver cirrhosis following carbon tetrachloride-induced liver 
toxicity in rats as ginger singly or either in combination with curcumin at 100 mg/
kg bw ameliorated the liver injury to the animal [94]. Additionally, ginger in 
another report at 200, 400 mg/kg bw fortified the activity of antioxidants enzymes 
(superoxide dismutase, catalase, glutathione peroxidase) while lowering the activ-
ity of liver function enzymes (alanine transaminase, aspartate aminotransferase) 
in the acetaminophen-induced hepatic injury [62] as also corroborated by Rahmani 
et al. [20] in several studies.
5.12 Toxicity profiles
Toxicity may be acute, subacute, chronic, and subchronic [95]. These stud-
ies are carried out to provide information about the safety profile of a substance. 
Medicinal plants are used as a form of therapeutic measure over a long period 
against numerous diseases. In fact, despite the fact that the active precursors of a 
number of chemical moieties or drugs are obtained from plant, the acceptance of 
herbal medicine and/or formulations are exceedingly growing globally. Intriguingly, 
80% of the entire global population are using herbal products for the maintenance 
of their health due to their perceived thought of originating from nature, lesser 
side effects, efficacy, safety, affordability, etc., although in some quarters, a very 
few of these medicinal plants have been reported to cause one form of illness (to 
the liver and kidney). However, report from several studies has not linked ginger in 
a way to any of these injuries. This fact is corroborated in reports ascertaining the 
safety of ginger in different concentrations, 0.5–1.0 g, 2.5 g/kg, 100, 333, 500, 1000, 
2000 mg/kg bw, in animal studies for different experimental study period ranging 
from 10 days, 35 days, 3 months to 2 and half years as nontoxic [20] even during 
pregnancy (rats) and gynecological operation as revealed by a clinical study [34].
5.13 Other pharmacological activities
The effectiveness of ginger against diseases affecting the eye and other ailments 
such as osteoarthritis, migraine attack, platelet aggregation, gastrointestinal distur-
bances, nematode invasion, etc. has been established [15, 17, 18, 20, 34].
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6. Conclusion
The world is filled with enormous diseases causing major setbacks to the health 
status of humanity. Unfortunately, the synthetic moieties adopted for therapeutic 
and preventive measures are not helping (at all) as they are characterized with side 
effects. Medicinal plants such as ginger are now being embraced as the alternative 
options for combating various simple or life-threatening ailments. Since various 
efforts had established the effectiveness of ginger and its corresponding derivatives 
on a number of ill-health (though lacking clinical reports), there is much hope 
in the future that ginger might be able to rescue humankind from these evolving 
derangements causing setbacks to their living and/or survival.
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